Vardenafil Hydrochloride Tablet
Product Images NDC 33342-153

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 33342-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil-str (Vardenafil Str)

Chemical structure of Vardenafil Hydrochloride, showing its molecular framework with labeled functional groups and the presence of hydrochloride trihydrate as indicated by X HCl x 3H2O.*

FDA Label Image

Vardenafil-fig-1 (Vardenafil Fig1)

A set of three line graphs showing mean maximal changes over time for systolic blood pressure, diastolic blood pressure, and heart rate in bpm. The x-axis represents timing of Vardenafil treatment pre-NTG at intervals of 24 hours, 8 hours, 4 hours, and 1 hour. The y-axes display mean maximal changes in units mmHg for blood pressures and bpm for heart rate, with data points connected by lines and error bars indicating variability.*

FDA Label Image

Vardenafil-fig-2 (Vardenafil Fig2)

A line graph depicting mean change in mmHg over 6 hours comparing placebo and 5 mg vardenafil under simultaneous and 6-hour separation conditions. The y-axis shows mean change in blood pressure, while the x-axis represents time in hours. Four distinct lines with different markers illustrate the data trends for each group over time.*

FDA Label Image

Vardenafil-fig-3 (Vardenafil Fig3)

A line graph showing mean change in mmHg over time (hours) comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The x-axis represents time in hours from 0 to 6, and the y-axis shows mean change in mmHg from -15 to 15. Four data series indicated by different symbols trace the effect trends across the time points.*

FDA Label Image

Vardenafil-fig-4 (Vardenafil Fig4)

A line graph depicting mean change in mmHg (y-axis) over time in hours (x-axis) for placebo and Vardenafil 10 mg and 20 mg doses across two stages. The graph shows four plotted series with placebo values fluctuating near zero, while Vardenafil doses show a decrease in mean change peaking near -8 mmHg around 2 to 4 hours before slightly rising.*

FDA Label Image

Vardenafil-fig-5 (Vardenafil Fig 5)

Line graph showing mean change in mmHg over time (hours) for Vardenafil Hydrochloride tablets at 5 mg and 10 mg doses compared to placebo across two stages. The x-axis represents time in hours from 0 to 6, and the y-axis represents mean change in mmHg from -10 to 10. Four data series are plotted using different symbols for placebo (stages 1 and 2) and Vardenafil (5 mg and 10 mg).*

FDA Label Image

Vardenafil-fig-6 (Vardenafil Fig 6)

A line graph titled 'TERAZOSIN' showing mean change in mmHg (y-axis) over time in hours (x-axis) up to 6 hours. The graph compares placebo, 10 mg vardenafil, and 20 mg vardenafil treatments under two conditions: 6-hour separation and simultaneous administration, using different symbols and line styles.*

FDA Label Image

Vardenafil-fig-7 (Vardenafil Fig 7)

A line graph titled 'TAMSULOSIN' depicting mean change in blood pressure (mmHg) over time (hours) for placebo and vardenafil dosages (10 mg and 20 mg), showing data for both 6-hour separation and simultaneous administration.*

FDA Label Image

Vardenafil-fig-8 (Vardenafil Fig 8)

A line graph depicting the plasma concentration (µg/L) of Vardenafil Hydrochloride over time (hours). The graph shows a rapid increase in plasma concentration peaking within 1-2 hours, followed by a steady decline to near zero by 24 hours. Error bars indicate variability at each time point.*

FDA Label Image

123 (Vardenafil 2 5mg 30s Bottle)

Packaging label for Vardenafil Hydrochloride Tablets 2.5 mg, oral tablets in a bottle of 30 tablets. Manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, with dosage instructions and storage conditions provided. The label includes barcode and drug identification codes.*

FDA Label Image

333 (Vardenafil 2 5mg 100s Bottle)

Label for Vardenafil Hydrochloride 2.5 mg oral tablets by Macleods Pharmaceuticals Limited. The label indicates the 2.5 mg strength per tablet, with packaging containing 100 tablets. It includes manufacturer information for Macleods Pharma USA in Plainsboro, NJ, and Macleods Pharmaceuticals Ltd. in India, along with dosing instructions and storage conditions.*

FDA Label Image

222 (Vardenafil 2 5mg 100s Carton)

The packaging label for Vardenafil Hydrochloride Tablets 2.5 mg, produced by Macleods Pharmaceuticals Limited. The box is designed for oral tablets, contains 100 tablets (10 x 10 unit dose), and includes storage instructions. It features manufacturer details, barcode, batch and expiration date fields, and dosage information advising to take one tablet as needed no more than once per day.*

FDA Label Image

666 (Vardenafil 5mg 30s Bottle)

Vardenafil Hydrochloride 5 mg oral tablets label by Macleods Pharmaceuticals Limited. The label indicates prescription use, contains 30 tablets, and includes storage instructions, manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd India, and a dosage note stating to take one tablet as needed, no more than once per day.*

FDA Label Image

345 (Vardenafil 5mg 100s Bottle)

Label for Vardenafil Hydrochloride Tablets 5 mg by Macleods Pharmaceuticals Limited. The film-coated tablets contain 5 mg equivalent of Vardenafil. The label includes dosing instructions, storage conditions, and manufacturer details. The package contains 100 tablets and is marked for pharmacist dispensing with accompanying patient information.*

FDA Label Image

432 (Vardenafil 5mg 100s Carton)

Vardenafil Hydrochloride Tablets 5 mg oral tablet packaging label from Macleods Pharmaceuticals Limited. The unit-dose carton contains 100 tablets (10 x 10 unit dose) and is labeled for prescription use only. Manufactured by Macleods Pharmaceuticals Ltd., India, and marketed by Macleods Pharma USA, Inc., Princeton, NJ. The label includes dosage instructions, storage information, and a barcode.*

FDA Label Image

555 (Vardenafil 10mg 30s Bottle)

Label for Vardenafil Hydrochloride Tablets 10 mg by Macleods Pharmaceuticals Limited. It shows the drug strength as 10 mg per tablet in a package of 30 tablets. The label includes storage instructions, usual dosage advice, manufacturer information (Macleods Pharma USA, Inc., Princeton, NJ, and Macleods Pharmaceuticals Ltd., India), and a barcode. It states the tablets are film-coated and dispensed with a patient information leaflet.*

FDA Label Image

554 (Vardenafil 10mg 100s Bottle)

Label for Vardenafil Hydrochloride oral tablets, 10 mg strength, by Macleods Pharmaceuticals Limited. The label indicates a package containing 100 film-coated tablets. It includes manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd., Daman, India, with instructions to dispense an accompanying Patient Information Leaflet.*

FDA Label Image

777 (Vardenafil 10mg 100s Carton)

Packaging label for Vardenafil Hydrochloride Tablets 10 mg, a film-coated oral tablet. The carton displays the product name, strength, and quantity (100 tablets, 10 x 10 unit dose) along with storage instructions and manufacturer information. The labeler is Macleods Pharmaceuticals Limited, manufactured in India for Macleods Pharma USA, Inc.*

FDA Label Image

667 (Vardenafil 20mg 30s Bottle)

Label for Vardenafil Hydrochloride Tablets 20 mg by Macleods Pharmaceuticals Limited. The oral tablet packaging contains 30 tablets. The label includes storage instructions, dosage guidance, and barcodes, with manufacturer address in Princeton, NJ, and facilities in India.*

FDA Label Image

554 (Vardenafil 20mg 100s Bottle)

Label for Vardenafil Hydrochloride tablets 20 mg by Macleods Pharmaceuticals Limited. The label notes each film-coated tablet contains vardenafil hydrochloride equivalent to 20 mg of vardenafil. It includes dosage instructions, storage conditions, and manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd. The package contains 100 oral tablets.*

FDA Label Image

555 (Vardenafil 20mg 50s Carton)

Packaging label for Vardenafil Hydrochloride Tablets 20 mg by Macleods Pharmaceuticals Limited. The label includes the product name, dosage strength (20 mg), manufacturer details, barcode, storage instructions, and package size of 50 tablets (5 x 10 unit dose). The label indicates the tablets are film-coated and oral dosage form intended for prescription use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.